12:00 AM
Apr 01, 2013
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Alimera Sciences, pSivida sales and marketing update

pSivida said partner Alimera will delay to 2Q13 from 1Q13 the German launch of Iluvien fluocinolone acetonide intravitreal implant to treat diabetic macular edema (DME). pSivida said the launch is expected upon...

Read the full 150 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >